Adamas Pharmaceuticals reported 108M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Aptinyx Inc APTX:US $ 132.41M 1.37M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
GlaxoSmithKline GSK:LN 18.25B 688M
Glaxosmithkline GSK:US $ 18254M 688M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Intra Cellular Therapies ITCI:US $ 533.24M 68.06M
Marinus Pharmaceuticals MRNS:US $ 153.49M 32.57M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Novartis NOVN:VX 26.25B 2.45B
Omeros OMER:US $ 91.35M 21.05M
Prothena PRTA:US 607.53M 198.06M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Zogenix ZGNX:US $ 375.46M 40.93M